[An observation on the treatment of Parkinson's syndrome; results with the new drug ParKS 12].
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D010880:Piperidines / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000031:analogs & derivatives
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010880:Piperidines; D014282:Trihexyphenidyl
MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy; PIPERIDINES/therapeutic use; TRIHEXYPHENIDYL/derivatives
Einige Uberlegungen zur Behandlung des Parkinson-Syndroms; Erfahrungen mit dem neuen Mittel ParKS 12.